Arc Co-Founder and CEO David Ewing Duncan gives an overview of Arc and its mission. Arc is supported by and seeks out the world’s top scientists, thinkers, executives, physicians, investors, entrepreneurs, advocates, policy makers, philosophers, writers, artists and other leaders who understand the need for personal involvement in the rising fusion phenomenon.
David Ewing Duncan
Founder & CEO, Arc Programs
David is an award-winning best-selling author of eight books published in 19 languages; he is a journalist and a television, radio and film producer and correspondent. His most recent book is When I’m 164: The new science of radical life extension, and what happens if it succeeds (TED Books).
He is a Correspondent for The Atlantic, and the Chief Correspondent of public radio’s Biotech Nation. He is series editor for Imminent Technologies at Perseus/Public Affairs. David writes for The New York Times, Fortune, National Geographic, Discover, and others.
He was the founder and host of BioAgenda and the Founding Director of the Center of Life Science Policy at UC Berkeley. He was a commentator on NPR’s Morning Edition, and a contributing editor for Wired, Discover, and Conde Nast Portfolio. He is a former special correspondent and producer for ABC Nightline.
David has won numerous awards including the Magazine Story of the Year from AAAS. His work has appeared in The Best American Science and Nature Writing.